Cargando…
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
The pathology of Alzheimer’s disease (AD) is characterized by dystrophic neurites (DNs) surrounding extracellular Aβ-plaques, microgliosis, astrogliosis, intraneuronal tau hyperphosphorylation and aggregation. We have previously shown that inhibition of the spleen tyrosine kinase (Syk) lowers Aβ pro...
Autores principales: | Schweig, Jonas Elias, Yao, Hailan, Beaulieu-Abdelahad, David, Ait-Ghezala, Ghania, Mouzon, Benoit, Crawford, Fiona, Mullan, Michael, Paris, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588676/ https://www.ncbi.nlm.nih.gov/pubmed/28877763 http://dx.doi.org/10.1186/s40478-017-0472-2 |
Ejemplares similares
-
Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
por: Verma, Megha, et al.
Publicado: (2015) -
Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
por: Verma, Megha, et al.
Publicado: (2015) -
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
por: Ringland, Charis, et al.
Publicado: (2021) -
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism
por: Paris, Daniel, et al.
Publicado: (2011) -
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013)